A randomized, double‐blind, phase
            III
            , multicentre study to evaluate the safety and efficacy of
            BF
            ‐200
            ALA
            (Ameluz
            ®
            ) vs. placebo in the field‐directed treatment of mild‐to‐moderate actinic keratosis with photodynamic therapy (PDT) when using the
            BF
            ‐Rhodo
            LED
            ®
            lamp

U. Reinhold; T. Dirschka; R. Ostendorf; R. Aschoff; C. Berking; W.G. Philipp‐Dormston; S. Hahn; K. Lau; A. Jäger; B. Schmitz; H. Lübbert; R.‐M. Szeimies

doi:10.1111/bjd.14498

A randomized, double‐blind, phase III , multicentre study to evaluate the safety and efficacy of BF ‐200 ALA (Ameluz ® ) vs. placebo in the field‐directed treatment of mild‐to‐moderate actinic keratosis with photodynamic therapy (PDT) when using the BF ‐Rhodo LED ® lamp

British Journal of Dermatology ◽

10.1111/bjd.14498 ◽

2016 ◽

Vol 175 (4) ◽

pp. 696-705 ◽

Cited By ~ 28

Author(s):

U. Reinhold ◽

T. Dirschka ◽

R. Ostendorf ◽

R. Aschoff ◽

C. Berking ◽

...

Keyword(s):

Photodynamic Therapy ◽

Multicentre Study ◽

Actinic Keratosis ◽

Phase Iii ◽

Double Blind ◽

Safety And Efficacy

Download Full-text

Follow-up results of a randomized, double-blind, phase III, multi-center study to evaluate the safety and efficacy of BF-200 ALA versus placebo in field-directed treatment of mild to moderate AK with photodynamic therapy when using narrowband red light

SKIN The Journal of Cutaneous Medicine ◽

10.25251/skin.3.supp.49 ◽

2019 ◽

Vol 3 ◽

pp. S49

Author(s):

U Reinhold ◽

T Dirschka ◽

R Ostendorf ◽

R Aschoff ◽

C Berking ◽

...

Keyword(s):

Photodynamic Therapy ◽

Red Light ◽

Phase Iii ◽

Double Blind ◽

Safety And Efficacy ◽

Multi Center Study ◽

Center Study

Abstract not available.

Download Full-text

A Phase III randomised, double-blind, multicentre study to evaluate the safety and efficacy of 1592U89 (abacavir) in human immunodeficiency virus 1-infected patients with aquired immune deficiency syndrome dementia complex

http://isrctn.org/> ◽

10.1186/isrctn53707238 ◽

2013 ◽

Author(s):

Bruce Brew

Keyword(s):

Immune Deficiency ◽

Human Immunodeficiency Virus ◽

Multicentre Study ◽

Immune Deficiency Syndrome ◽

Deficiency Syndrome ◽

Phase Iii ◽

Double Blind ◽

Safety And Efficacy ◽

Immunodeficiency Virus ◽

Human Immunodeficiency Virus 1

Download Full-text

Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a prospective, randomized, double-blind, placebo-controlled phase III study

British Journal of Dermatology ◽

10.1111/j.1365-2133.2010.09873.x ◽

2010 ◽

Vol 163 (2) ◽

pp. 386-394 ◽

Cited By ~ 55

Author(s):

R.-M. Szeimies ◽

P. Radny ◽

M. Sebastian ◽

F. Borrosch ◽

T. Dirschka ◽

...

Keyword(s):

Photodynamic Therapy ◽

Actinic Keratosis ◽

Phase Iii ◽

Double Blind ◽

Double Blind Placebo ◽

Phase Iii Study

Download Full-text

Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a prospective, randomized, double-blind, placebo-controlled phase III study

Yearbook of Dermatology and Dermatologic Surgery ◽

10.1016/j.yder.2011.02.044 ◽

2011 ◽

Vol 2011 ◽

pp. 369-370

Author(s):

G. Martin

Keyword(s):

Photodynamic Therapy ◽

Actinic Keratosis ◽

Phase Iii ◽

Double Blind ◽

Double Blind Placebo ◽

Phase Iii Study

Download Full-text

A randomized, double blind, vehicle-controlled multicenter phase III study to evaluate the safety and efficacy of BF-200 ALA and narrowband red light in the treatment of superficial basal cell carcinoma (sBCC) with photodynamic therapy (PDT)

SKIN The Journal of Cutaneous Medicine ◽

10.25251/skin.3.supp.48 ◽

2019 ◽

Vol 3 ◽

pp. S48

Author(s):

V Laquer ◽

S Bruce ◽

T Schlesinger ◽

N Zeitouni ◽

A Torres ◽

...

Keyword(s):

Photodynamic Therapy ◽

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Red Light ◽

Phase Iii ◽

Double Blind ◽

Safety And Efficacy ◽

Multicenter Phase ◽

Phase Iii Study ◽

Superficial Basal Cell Carcinoma

Abstract not available.

Download Full-text

A phase III, randomised, double blind, multicentre study to evaluate the safety and efficacy of dalbavancin versus linezolid in the treatment of complicated skin and soft tissue infections with suspected gram-positive bacterial pathogens

http://isrctn.org/> ◽

10.1186/isrctn63718248 ◽

2012 ◽

Author(s):

Martin Wiselka

Keyword(s):

Soft Tissue ◽

Multicentre Study ◽

Bacterial Pathogens ◽

Phase Iii ◽

Soft Tissue Infections ◽

Gram Positive ◽

Double Blind ◽

Safety And Efficacy ◽

Complicated Skin

Download Full-text

Faculty Opinions recommendation of A phase III, randomized, double-blind, parallel-group, placebo-controlled, multicentre study to assess the efficacy and safety of the β₃ adrenoceptor agonist, mirabegron, in patients with symptoms of overactive bladder.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718020708.793482011 ◽

2013 ◽

Author(s):

Francisco Cruz

Keyword(s):

Overactive Bladder ◽

Multicentre Study ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Adrenoceptor Agonist ◽

Parallel Group

Download Full-text

Faculty Opinions recommendation of A phase III, randomized, double-blind, parallel-group, placebo-controlled, multicentre study to assess the efficacy and safety of the β₃ adrenoceptor agonist, mirabegron, in patients with symptoms of overactive bladder.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718020708.793480560 ◽

2013 ◽

Author(s):

Howard Goldman ◽

Alana M Murphy

Keyword(s):

Overactive Bladder ◽

Multicentre Study ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Adrenoceptor Agonist ◽

Parallel Group

Download Full-text

Safety and efficacy of alternating treatment with EP2006, a filgrastim biosimilar, and reference filgrastim: a phase III, randomised, double-blind clinical study in the prevention of severe neutropenia in patients with breast cancer receiving myelosuppressive chemotherapy

Annals of Oncology ◽

10.1093/annonc/mdx638 ◽

2018 ◽

Vol 29 (1) ◽

pp. 244-249 ◽

Cited By ~ 10

Author(s):

K. Blackwell ◽

P. Gascon ◽

A. Krendyukov ◽

S. Gattu ◽

Y. Li ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Study ◽

Phase Iii ◽

Severe Neutropenia ◽

Double Blind ◽

Myelosuppressive Chemotherapy ◽

Safety And Efficacy

Download Full-text

Trial design of a phase III, multicentre, randomised, double-blind, placebo-controlled, 48-week study to evaluate the safety and efficacy of osilodrostat in patients with Cushing's disease

Endocrine Abstracts ◽

10.1530/endoabs.41.ep937 ◽

2016 ◽

Author(s):

Richard A Feelders ◽

Anthony Heaney ◽

Karen McBride ◽

Annie Hilliard ◽

Chuan Tian ◽

...

Keyword(s):

Cushing’S Disease ◽

Trial Design ◽

Phase Iii ◽

Cushing's Disease ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo

Download Full-text